The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial
Christopher G. Davey(The University of Melbourne), Michael Berk(The Royal Melbourne Hospital), Sue Cotton(Monash University), Nikolaos Kazantzis(Women's and Children's Health Network), John Koutsogiannis(Orygen Youth Health), Amber Weller(The University of Melbourne), Aswin Ratheesh(The University of Melbourne), Melissa Kerr(The University of Melbourne), Olivia Dean(Antwerp University Hospital), Andrew M. Chanen(Orygen Youth Health), Alexandra Parker(The University of Melbourne), Patrick D. McGorry(Orygen Youth Health), Lisa Catania(The University of Melbourne), Mark Phelan(Orygen), Sarah Hetrick(University of Auckland), Simon Rice(The University of Melbourne), Amelia L. Quinn(The University of Melbourne), Ben J. Harrison(The University of Melbourne)
Cited by 109
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
|The Lancet Psychiatry|2019|1.5k
So depression is an inflammatory disease, but where does the inflammation come from?
|BMC Medicine|2013|1.4k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754